Canadians Face Longer Wait for Copycat Ozempic on Filing Holdup
Canadians face a longer-than-expected wait for cheaper versions of Novo Nordisk A/S’s diabetes drug Ozempic after two of…
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
Novo Halves Ozempic Price to $499 a Month for Cash-Pay Patients
Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the…
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss…